The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Net Income

Bottom-line profit after all expenses, interest, and taxes.

The Oncology Institute, Inc.NASDAQ: TOI

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income remains negative

Q1 FY2026 net income was -$2.49M, compared with -$19.59M a year earlier. Trailing-twelve-month net income was -$43.51M.

Context

  • Net income amounted to 12.1% of revenue in FY2025, down 4.4 pp from a year earlier.
  • Net income increased in 2 of the last 3 fiscal years.

What to watch

Whether net income reaches the consensus estimate from 3 analysts of -$138.58M (-128.7%) for the fiscal year ending Dec 2026, a slowdown from the +6.3% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$2.49M+66.8% QoQ
Last fiscal yearDec 2025
-$60.61M+6.3% YoY
LTMMar 2026
-$43.51M+32.4% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+87.3%-256.8%-344.0 pp
1 year+6.3%-128.7%-134.9 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the income statement

Latest · FY2025
(60.61M) USD
Year-over-year change
+6.3%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +32.4% is the highest of 10, against a peer median of -35.7%.
  • Net income amounts to 8.0% of revenue for TOI, versus a peer median of 16.3%.
TOI Competitors
Net Income for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 68.14M PEN-57.2%—1.5%
KIDSOrthoPediatrics Corp.LTM Mar 2026-$39.68M USD+2.5%—16.3%
EOLSEvolus, Inc.LTM Mar 2026-$43.42M USD+22.7%—14.4%
TOIThe Oncology Institute, Inc.LTM Mar 2026-$43.51M USD+32.4%—8.0%
CBLLCeriBell, Inc.LTM Mar 2026-$60.37M USD-35.7%—63.5%
TMCITreace Medical Concepts, Inc.LTM Mar 2026-$61.04M USD-15.2%—29.4%
CCRNCross Country Healthcare, Inc.LTM Mar 2026-$98.63M USD-456.0%—9.8%
SNDASonida Senior Living, Inc.LTM Mar 2026-$99.48M USD-139.1%—24.2%
AUTLAutolus Therapeutics plcLTM Mar 2026-$288.83M USD-21.3%—312.0%
AGLAgilon Health, Inc.LTM Mar 2026-$373.49M USD-54.3%—6.4%
Peer median (excluding TOI) —-35.7%—16.3%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.